Original Query: ALL
Previous Study | Return to List | Next Study

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004393
Recruitment Status : Completed
First Posted : October 19, 1999
Last Update Posted : June 24, 2005
Yale University
Information provided by:
Office of Rare Diseases (ORD)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2000